Evidence map›Paper›PMID 24776220›Full record

ArticleCarcinogenesis2014

A critical role of non-classical MHC in tumor immune evasion in the amphibian Xenopus model.

Nikesha Haynes-Gilmore, Maureen Banach, Eva-Stina Edholm, Edith Lord, Jacques Robert

Open access · bronzeAbstract read
In one paragraph

Article in Carcinogenesis, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
1.5field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 23 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Article
  5. Xenbase: Facilitating the Use ofFrontiers in physiology · 2019
    Review
  6. Frontiers in physiology · 2018
    Review
  7. Article
  8. Review
  9. Article
  10. Review
  11. Review
  12. Review
  13. Article
  14. Evolution of nonclassical MHC-dependent invariant T cells.Cellular and molecular life sciences : CMLS · 2014
    Review
  15. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Nikesha Haynes-GilmoreDepartment of Microbiology and Immunology and Department of Pathology, University of Rochester Medical Center, Rochester, NY 14642, USA.
Maureen BanachDepartment of Microbiology and Immunology and.
Eva-Stina EdholmDepartment of Microbiology and Immunology and.
Edith LordDepartment of Microbiology and Immunology and.
Jacques RobertDepartment of Microbiology and Immunology and jacques_robert@urmc.rochester.edu.
University of Rochester Medical Center · US

Funding

A Xenopus Laevis Research Resource for ImmunologyR24AI059830 · NIAID · UNIVERSITY OF ROCHESTER · PI JACQUES Robert · 2004 to 2026
$7.7M
The T32 Predoctoral Training Program in Immunology (PTPI)T32AI007285 · NIAID · UNIVERSITY OF ROCHESTER · PI Scott Andrew Gerber, JACQUES Robert · 1986 to 2026
$7.6M
The role of The Xenopus Nonclassical MHC class I molecule XNC10 in Tumor ImmunityF31CA192664 · NCI · UNIVERSITY OF ROCHESTER · PI BANACH, MAUREEN LUDMILA · 2015 to 2018
$153k
NCI NIH HHS F31 CA192664NIAID NIH HHS R24-AI-059830NIAID NIH HHS T32 AI007285
6 · The paper itself

Abstract

Non-classical class Ib (class Ib) genes are found in all jawed vertebrates, including the amphibian Xenopus, which possesses at least 20 distinct Xenopus non-classical class Ib genes (XNCs). As an immune evasion strategy, tumors often downregulate surface expression of classical major histocompatibility complex class Ia molecules. In contrast, cancers commonly express class Ib molecules, presenting an alternative for tumor immune recognition. We characterized a novel XNC, XNC10, functionally similar to CD1d from a class Ia-deficient thymic lymphoid tumor (15/0), which grows aggressively in Xenopus LG-15 cloned animals. To investigate the roles of XNC10 in antitumor immunity, we generated stable 15/0-transfectants with silenced XNC10 mRNA and protein expression. Notably, XNC10 silencing resulted in acute tumor rejection by naturally class Ia-deficient syngeneic tadpoles, with greater potency of rejection in tumors with more efficient XNC10 knockdown. In vivo killing assays shows that the rejection of XNC10-deficient tumors is due to a cell-mediated cytotoxic immune response elicited by the tadpole host. Importantly, priming enhances XNC10-deficient tumor rejection. Flow cytometry reveals that XNC10-deficient tumor rejection is associated with an accumulation of XNC10-restricted invariant T cells and conventional CD8 T cells as well as other leukocytes. Similarly, semisolid tumor grafts in tadpoles also exhibit leukocytes infiltration. These findings suggest that XNC10 allows the 15/0-tumor to escape immune recognition and class Ia-independent cytotoxicity, thus emphasizing the critical roles of class Ibs in tumor immunity.

Indexed as

AnimalsBlotting, WesternCD8-Positive T-LymphocytesFemaleFlow CytometryHistocompatibility Antigens Class IImmunoenzyme TechniquesLarvaLymphoid TissueReal-Time Polymerase Chain ReactionReverse Transcriptase Polymerase Chain ReactionRNA, MessengerThymus NeoplasmsTumor EscapeXenopus laevisXenopus ProteinsHistocompatibility Antigens Class IRNA, MessengerXenopus Proteins

Identifiers

PMID24776220
PMCPMC4123649
OpenAlexW2118316871

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.